|Articles|August 31, 2018
CRF Health Partners Innovative US Biotech with TrialMax eCOA Solution
Advertisement
CRF Health, a provider of patient-centered eSource technology solutions for the life sciences industry, announced that its TrialMax Slate solution has been selected by a US biotech company for a global Phase III prostate cancer study.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Establishing Governance for No-Code AI in Clinical Operations
2
Applied Clinical Trials' 2025 State of the Industry Survey
3
Do Phase II Protocol Learnings Help Simplify Phase III Protocol Designs?
4
The Confidence Trap in Clinical Trials: When Knowing Just Enough Becomes Dangerous
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
